Blog
0
Talvey Giving Patients With Heavily Pretreated Multiple Myeloma ‘a New Lease on Life’
0

The recent Food and Drug Administration (FDA) accelerated approval of Talvey (talquetamab-tgvs) for patients with heavily pretreated multiple myeloma ...

0
My Experience with Lynch Syndrome
0

Scrolling through the #Lynchsyndrome hashtag on Instagram has become a source of writing inspiration for me. Amidst the posts' stats, cancer journeys and ...

0
Survivor Care Plans Lead to Higher Follow-Up Care Retention Rates
0

Survivor care plans are beneficial to survivors of cancer in terms of receiving cancer-related follow-up care, a recent study found.For both adult survivors ...

0
Retired Teacher Turns to Former Student for Innovative Bladder Cancer Care
0

It’s been more than 35 years since Peter Kahan and Dr. Ravi Munver first met. Back then, they were a teacher and his student, respectively. These days, the ...

0
2022/23 in review: Cancer Research UK reports good progress in a tough climate – Cancer Research UK
0

Progress for people affected by cancer  Small but important changes to treatments can have a big difference for patients.   Earlier this year, the ...

0
Presentation and Diagnosis of Prostate Cancer
0

Clinical insights on the typical presentation of prostate cancer and how the disease is diagnosed.

0
How patients with leukemia and lymphoma can explore clinical trial enrollment
0

Transcription:Biese: Hi, my name is Alex Biese. I'm the assistant managing editor of CURE magazine, and in this edition of the "Speaking Out" video series, ...

0
‘Help out there’ for patients with leukemia and lymphoma through education, support programs
0

Transcription:Alex Biese: Hi, my name is Alex Biese. I'm the assistant managing editor of CURE magazine. In this edition of the "Speaking Out" video series, ...

0
What developments in bispecific antibodies mean for patients with leukemia and lymphoma
0

Transcription:Alex Biese: Hi, my name is Alex Biese, and I'm the assistant managing editor of CURE magazine. In this edition of the Speaking Out video ...

0
What treatments for leukemia and lymphoma are on the way?
0

Transcription: Hi, my name is Alex Biese. I'm the assistant managing editor of CURE magazine, and in this edition of the Speaking Out video series, on ...

0
Patients with leukemia and lymphoma face racial disparities, financial toxicity, treatment side effects
0

Transcription:Alex Biese: Hi, my name is Alex Biese. I'm the assistant managing editor of CURE magazine. In this edition of the Speaking Out video series, ...

0
Expert Panel to Review Lumakras for KRAS G12C-Mutant Lung Cancer
0

A panel of experts will vote on whether Lumakras (sotorasib) should be approved for the treatment of adults with previously treated locally advanced or ...

CML Alliance
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart